Genome-wide profiling identified seven lncRNAs (lncCol4A2-1, lncZNF726-4, lncDNAJB11-6, lncMYOT-1, lncPRKCQ-1, lncCXADR-1, and lncZNF99-6) upregulated in MM cell lines and CD138+ plasma cells resistant to proteasome inhibitors compared to sensitive cells, suggesting their involvement in drug resistance [123]. The gene discussed is SDC1; the disease is Miyoshi myopathy.